Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

Press/Media

Period	5 Mar 2024

Media coverage

Title	Ironwood Pharmaceuticals Announces Positive Topline Results from Global Phase III Trial of Once-Weekly Apraglutide in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
Media name/outlet	Drugs.com
Country/Territory	United States
Date	5/03/24
URL	https://www.drugs.com/clinical_trials/ironwood-pharmaceuticals-announces-positive-topline-results-global-phase-iii-trial-once-weekly-21368.html
Persons	Kishore Iyer